🎮Fanatical about gaming? Me too! Grab epic deals on games with top-notch service using my link: https://t.co/GudJ0qDwcc. Shop now and level up your collection! #Fanatical#GamingDeals
Stop empowering developers with dogshit fake frames.
You keep turning the industry into soulless slop with the unending race to releasing games faster at all costs.
We know you don't care about the quality of games, you made it very clear.
You turned into a disease to mankind.
@AmazonHelp Hello. Amazon UK aren’t honouring the consumer rights act of 2015 and are actively refusing to accept a return an item that has developed a fault. Naughty, I bet trading standards would love this.
**The injection contains recombinant AIM (Apoptosis Inhibitor of Macrophage) protein** — a naturally occurring blood protein produced via mammalian cell culture.
Cats (unlike humans, dogs, or mice) have a genetic quirk: their AIM binds too tightly to IgM and can't properly reach the kidneys to flag and clear dead cell debris from renal tubules. This leads to chronic kidney disease, the #1 cause of feline death. The therapy supplies functional AIM to restore that cleanup process.
It's not vague — Dr. Toru Miyazaki's team at the University of Tokyo has published the mechanism for years. Clinical trials (including recent larger ones) show strong results in advanced CKD cases. Approval is targeted around 2027 in Japan. Details are in their research; it's not a mystery formula, just not commercially available yet.
Scientists in Japan have developed a groundbreaking treatment that could double the average lifespan of cats, extending it from around 15 years to nearly 30 years.
The key lies in a protein called AIM (Apoptosis Inhibitor of Macrophage), discovered by Dr. Toru Miyazaki. While cats naturally produce AIM, they lack the ability to activate it effectively. This deficiency leads to the gradual buildup of waste in the kidneys, the leading cause of death in domestic cats.
Dr. Miyazaki’s team created an injectable form of activated AIM that directly restores the kidneys’ natural cleaning function. In clinical trials, cats with advanced kidney disease showed dramatic improvement after treatment. The therapy works both as a preventive measure for healthy cats and as a treatment for those already ill.
If approved, the treatment could revolutionize feline healthcare. Commercial rollout is expected to begin in Japan as early as 2025, with wider availability projected for 2027.
The research has also sparked interest for its potential applications in human medicine, as the AIM protein plays a similar waste-clearing role across species.
My reply to someone considering starting a video game company:
The distribution of possible rewards for starting a video game company are generally not very good today. The market is well served, and gaining a foothold requires strong execution on both business and product issues, along with a substantial amount of luck. Plan to burn through seven figures with a not-great chance of making it back.
If you do go for it, some bits of advice:
Identify your customers clearly before you start. Not just a broad community, but specific people, and imagine them as you make decisions.
Initially, build the smallest, most concise game you can imagine anyone paying for. It will still take much longer than you expect.
Once something exists, hill-climb the value. Hopefully you will have some elements that clearly bring joy to people, which you can magnify. There will inevitably be tons of things that people find confusing, frustrating, or just boring that you will need to fix.
STEAM CONTROLLER GIVEAWAY 😳🔥
Seeing how many people were disappointed with the scalper situation, I decided to giveaway the only unit I was able to buy.
1️⃣ • Like & Retweet
2️⃣ • Follow me @gabefollower
Winner will be picked in THREE weeks 🏆